This report is an intraday check of some of the more notable stocks that have hit a 52-week high or low so far today. 52-Week High:
- Pfizer Inc.
(NYSE: PFE) high of $22.17. Earlier Tuesday, Medivation (Nasdaq: MDVN) and Pfizer (NYSE: PFE) announced results from the CONCERT trial, which is a Phase 3 trial that evaluated dimebon (latrepirdine) when added to ongoing treatment with donepezil HCL tablets in patients with mild-to-moderate Alzheimer's disease.
Dimebon did not achieve statistically significant results...
Post new comment